Related Experiment Video
Updated: Sep 20, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Elevated amputation rates in COVID-19 survivors: Insights from a large-scale Japanese cohort study
Daisuke Miyamori1, Shuhei Yoshida1, Masanori Ito1
1Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Insights
COVID-19 survivors face a doubled risk of amputation, a complication that persists for over two years. This elevated risk is particularly pronounced in individuals with multiple underlying health conditions, underscoring the need for ongoing vascular monitoring.
Area of Science:
- Vascular Medicine
- Infectious Diseases
- Epidemiology
Background:
- COVID-19 is associated with vascular complications.
- Long-term data on amputation risk following COVID-19 infection is limited.
- Understanding post-COVID-19 vascular sequelae is crucial for patient management.
Purpose of the Study:
- To evaluate the long-term risk of amputation in individuals after COVID-19 infection.
- To assess the impact of COVID-19 on amputation rates using a large-scale Japanese health insurance database.
- To identify factors influencing amputation risk in COVID-19 survivors.
Main Methods:
- Retrospective cohort study utilizing the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
- Propensity score matching to create balanced cohorts of COVID-19 exposed and unexposed individuals.
- Analysis of amputation incidence and calculation of incidence rate ratios (IRRs) and differences (IRDs) with sensitivity and subgroup analyses.
Main Results:
- Over 3 million matched pairs were analyzed, with a median follow-up of 7 months.
- COVID-19 survivors exhibited a 2.33-fold increased risk of amputation (IRR 2.33; 95% CI 1.88-2.90).
- Elevated amputation risk persisted beyond 2 years post-infection and was significantly higher in those with a greater comorbidity burden (Charlson Comorbidity Index ≥2).
Conclusions:
- COVID-19 infection is linked to a sustained increase in amputation rates among survivors.
- The heightened risk of amputation post-COVID-19 is exacerbated by the presence of multiple comorbidities.
- Long-term monitoring and proactive management of vascular complications are essential for COVID-19 survivors, especially those with pre-existing health conditions.
Objective:
COVID-19 has been linked to increased vascular complications, but its long-term impact on amputation rates is unclear. This study evaluated amputation risk post-COVID-19 using a nationwide insurance claims database in Japan.
Methods:
We conducted a retrospective cohort study using data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan. COVID-19 cases were identified via insurance payment waivers, and amputations were defined by procedure codes. Propensity score matching created balanced cohorts of COVID-19 exposed and unexposed individuals. Matched cohorts were compared for amputation incidence, calculating incidence rate ratios (IRRs), and differences (IRDs). Sensitivity analyses examined outcomes at different time points, and subgroup analyses stratified results by key characteristics.
Results:
This study included 3,098,948 matched pairs. Over a median follow-up of 7 months, 286 amputations occurred in the COVID-19 group vs 123 in controls (IRR 2.33, 95% CI 1.88-2.90; IRD 5.57 per 1,000,000 person-months, 95% CI 4.22-6.92). The elevated risk persisted beyond 2 years post infection (IRR 2.03, 95% CI 1.31-3.20). Subgroup analyses showed higher risks in individuals with higher comorbidity burden (Charlson Comorbidity Index [CCI] ≥2; IRR 2.45 95% CI 1.92, 2.79) vs lower comorbidity burden (CCI 0-1; IRR 0.71 95%CI 0.29, 1.71) with significant interaction (P = 0.04).
Conclusions:
Amputation rates increased among COVID-19 survivors, persisting for over 2 years post infection. The interaction between COVID-19 and comorbidity burden highlights the need for vigilant long-term monitoring and management of vascular complications in COVID-19 survivors, particularly those with multiple comorbidities.
More Related Videos
08:16High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Peripheral Artery Disease V: Postoperative Nursing Management
Bias in Epidemiological Studies
Cancer Survival Analysis
Peripheral Artery Disease I: Introduction
Relative Risk